Anemia

While clinical trials have shown hypoxia-inducible factor prolyl hydroxylase inhibitors to be non-inferior to other anemia drugs, questions remain about IV or oral iron supplementation and inflammation, according to a new report.

The FDA approved momelotinib for treatment of patients with myelofibrosis and anemia regardless of prior myelofibrosis therapy.

Providing iron supplements during prenatal visits improved hematocrit levels and anemia rates and reduced transfusions for acute blood loss anemia among women with Medicaid insurance, researchers reported.

The FDA approved luspatercept-aamt as first-line treatment for anemia among certain adults with myelodysplastic syndrome.

Healio spoke with David Andrew Sallman, MD, about recent advancements and approvals in myelodysplastic syndrome.

In this video, Ruben Mesa, MD, discussed the backstory behind a study presented at ASCO Annual Meeting, examining the effect of luspatercept on patients with myelofibrosis suffering from anemia.

In this video, Ruben Mesa, MD, discussed a study he presented at ASCO Annual Meeting examining the impact of transfusion burden on quality of life and functioning on patients with myelofibrosis.

Iron deficiency appeared common among a cohort of U.S. females aged 12 years to 21 years, with an overall prevalence of nearly 40%, according to study results published in a research letter in JAMA.

Taking daily low-dose aspirin was linked to an increased incidence of anemia and a decline in blood iron levels among otherwise healthy older adults, according to the results of research published in Annals of Internal Medicine.